"This edition of UNAIDS data highlights these challenges and successes. It contains the very latest data on the world’s response to HIV, consolidating a small part of the huge volume of data collected, analysed and refined by UNAIDS over the years. The full data set of information ...

In many sub-Saharan African countries, declines in child mortality combined with a slow decline in fertility have resulted in children and young adults comprising a large part of the overall population. This is known as the youth bulge. The youth bulge is not new. Younger ...

The global AIDS response is at a precarious point—partial success in saving lives and stopping new HIV infections is giving way to complacency. At the halfway point to the 2020 targets, the pace of progress is not matching the global ambition. This report is a ...

Although much has been written on HIV-sensitive social protection, there is insufficient guidance on how to bring to scale what works in the context of different HIV epidemics and for different populations. This document seeks to fill this gap. It provides guidance to governments, people ...

In 2016, 29444 people were diagnosed with HIV in the 31 countries of the EU/EEA, with a rate of 5.9 per 100000 when adjusted for reporting delay (Table  1; Annex  6). Countries with the highest rates of new HIV diagnoses reported in 2016 were Latvia ...

The international community has committed to ending the AIDS epidemic as a public health threat by 2030 – an ambitious target of the 2030 Agenda for Sustainable Development adopted by the United Nations General Assembly in September 2015. Interim targets have been established for 2020. ...

Efavirenz is one of the most widely used nonnucleoside reverse transcriptase inhibitors (NNRTIs) in first-line antiretroviral therapy (ART) and is recommended as a preferred option in adult treatment guidelines. However, data from primate studies and some human case reports have raised concern regarding a association ...

Despite decreases in the rate of spread in the last decade, the number of new HIV diagnoses in Europe continues to increase, and by 2011, reached over 1.2 million individuals, with over half a million diagnoses reported in the last five years. Between 2006 and ...

Background Timely assessment of the burden of HIV/AIDS is essential for policy setting and programme evaluation. In this report from the Global Burden of Disease Study 2015 (GBD 2015), we provide national estimates of levels and trends of HIV/AIDS incidence, prevalence, coverage of antiretroviral therapy (ART), ...

Over the past 15 years, the world has made remarkable strides in halting and reversing the HIV epidemic: annual new infections have declined 35% since 2000 and 15 million people living with HIV (PLHIV) are now on antiretroviral therapy (ART). However, the key populations (KPs) ...

Conclusions: HIV infection is of major public health importance in the EU/EEA, with no clear signs of overall decrease. During the past decade (2005-2014) there have been important epidemiological changes in HIV diagnoses in the EU/EEA: Sex between men accounted for the majority of cases diagnosed ...

Abstract book of "AIDS 2016. 21st international AIDS conference" which was from 18 to 22 July 2016 in Durban, South Africa.